Braze, Inc. (BRZE)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-14
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-14
Research Workspace
Put BRZE beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Application Software is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 27% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 56% in its worst 12-month stretch.
View RiskBraze's growth trajectory relies on its ability to expand AI adoption and revenue. The company recently raised its FY2027 revenue forecast to $910M-$913M, supported by strong Q2 results. It trades at 3.2× price-to-sales, below the 3.4× peer median, indicating modest growth expectations. A significant risk is the potential for guidance cuts, which could lead to further stock declines. Peer multiples imply a price about 14% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-14. BRZE is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 21 analysts currently covering BRZE (as of Sep 2026).
Based on 11 Wall Street analysts offering 12-month price targets for BRZE in the last 4 months.
Continue this research
Compare BRZE with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BRZE Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 5 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Application Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put BRZE next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase revenue and accelerate organic growth
Analyst upgrade indicates confidence in revenue growth potential.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $25.60
The last 12 months of price, then the range of analyst 12-month targets from today’s $25.60.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Advances: Increase revenue and accelerate organic growth
Revenue forecast aligns with growth objectives and AI expansion.

Surpassing estimates supports revenue growth objectives.

Weak guidance indicates potential revenue growth issues.

Earnings beat indicates positive momentum for revenue.

Price target increase indicates positive revenue outlook.

Earnings beat and updated guidance support revenue growth.
Earnings beat and raised guidance confirm growth objectives.